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T Cell Receptor Transfection Shows Non-HLA-Restricted
Recognition of Nickel by CD8þ Human T Cells to be Mediated
by abT Cell Receptors
Corinne Moulon,1 Yoanna Choleva,2 Hermann-Josef Thierse, DorisWild and Hans UlrichWeltzien
Max-Planck-Institut fˇr Immunbiologie, Freiburg, Germany
CD8þ T cells have been assigned a prominent role in
allergic contact dermatitis, including nickel allergy;
however, human nickel-reactive T cells of the CD8þ
phenotype have largely escaped detailed investigation.
Here we characterize two quite unusual nickel-speci¢c
cytotoxic T cell clones isolated from the peripheral
blood of two nickel-sensitized patients. These clones
mediate nickel-speci¢c cytolysis of many human cell
lines, independent of the expression of HLA class I,
CD1, or HLA class II molecules. Lysis is mediated by
the ab T cell receptors and involves the perforin, but
not the Fas/Fas ligand pathway. Both antigen receptors
lack sequence homology to each other as well as to typi-
cal natural killer T cell receptors. A transfectant expres-
sing the rearranged ab T cell receptor derived from one
of theTcell clones unequivocally demonstrates that theT
cell receptor itself is necessary and su⁄cient to confer
HLA-independent nickel speci¢city. The independent
isolation of these clones from two individuals points to
an important role of such cells in the pathology of nickel
contact dermatitis. Key words: allergy/Killer cell/MHC/
TCR/Cytolysis. J Invest Dermatol 121:496 ^501, 2003
T
cells from nickel (Ni)-sensitized individuals respond
to Ni salts in the presence of HLA-matched antigen-
presenting cells (APC) by proliferation and secretion
of interleukins (IL) (Sinigaglia et al, 1985; Kapsenberg
et al, 1987). The majority of the Ni-responsive cells
express CD4, but some 20% are CD8þ (Werfel et al, 1997; Cavani
et al, 1998; Moulon et al, 1998). Prolonged in vitro propagation and
limiting dilution cloning usually further favor the CD4þ popu-
lation (Moulon et al, 1995, 1998). Thus, most studies involving
cloned Ni-reactive T cells have been performed with CD4 cells.
On the other hand, it has become evident from animal models
with contact allergens such as trinitrochlorobenzene or dinitro-
chlorobenzene that CD8þ T cells constitute the major cellular
population eliciting and maintaining skin reactions upon allergen
contact (Bour et al, 1995; Martin et al, 2000).
In Ni allergy a dominant role has also been assigned to CD8þ
T cells (Cavani et al, 1998, 2001); however, very little information
is available concerning the antigenic determinants recognized by
HLA class I restricted, Ni-speci¢cT cell receptors (TCR).We and
others have cloned several CD8þ cytotoxic T cells from human,
Ni-reactiveTcell lines (Cavani et al, 1998; Moulon et al, 1998). The
majority of these clones exhibited typical HLA class I restriction.
We also identi¢ed a CD8þ cytotoxicTcell clone (L1.1), however,
which did not depend on the expression of HLA molecules (clas-
sical class I or II) on target or stimulator cells to respond either by
cytotoxicity or proliferation to Ni ions (Moulon et al, 1998).
At that time, clone L1.1 appeared to be a strange exception to
the rule; however, we have subsequently identi¢ed a second
CD8þ clone with comparable properties from a di¡erent Ni-al-
lergic donor.We therefore considered that the frequency of such
cells might be high enough to be of functional importance in Ni
allergic patients. This prompted us to initiate a detailed investiga-
tion of these two T cell clones in order to de¢ne the extent to
which antigen speci¢city was de¢ned by their ab TCR and
whether other surface molecules may be involved.
MATERIALS ANDMETHODS
Patients Two Ni allergic donors participated in this study after giving
informed consent. Approval no. 156/97 was granted by the ethics
commission of the medical faculty, Freiburg. Ni allergy was evaluated
according to the standard procedure using epicutaneous application of
NiS04.6H2O at 5% in vaseline using the Finn chamber method. The HLA
haplotypes of the donors were the following: donor CMO (HLA-A2, B27,
B51(5), DR1, DR11, DR52, DQ5(1), DQ7(3), donor IF (HLA-A1, A6610,
B35, B53, Cw4, DR4, DR13(6), DR52, DR53, DQ6(1), DQ7(3)).
Media and additions The culture medium was RPMI 1640
supplemented with 2 mM L-glutamine, 100 mg kanamycin per mL,
510^5 M 2-mercaptoethanol, 1 mM sodium pyruvate, 1mixture of
nonessential amino-acids (all from Gibco BRL, Eggenstein, Germany),
and 5% pooled human AB serum (RPMI-HS) or 10% heat-inactivated
fetal bovine serum (RPMI-FBS). To support the antigen-independent
growth of T cell clones, this medium was supplemented with 100 U per
mL recombinant human IL-2 (Eurocetus, Ratingen, Germany). Stock
solutions of 38 mM NiSO4.6H2O were stored at 201C and added at
10^4 M ¢nal concentration if not indicated otherwise. Concanamycin A
(CMA) was from Sigma (Deisenhofen, Germany), and Staphylococcus
aureus enterotoxin B from Serva (Heidelberg, Germany).
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Ni-speci¢c Tcell lines and clones Peripheral blood mononuclear cells
(106 per mL) isolated by Ficoll-Hypaque (Pharmacia, Freiburg, Germany)
were cultivated in vitro with 10^4 M NiSO4 in RPMI-HS for 7 d in a ¢nal
volume of 5 mL in six-well culture plates. Cells were then washed and
expanded in IL-2-containing RPMI-HS for another 5 d. These lines were
stimulated a second time with 10^4 M NiSO4 and irradiated (3000 rad)
autologous peripheral blood mononuclear cells (106 per mL) and, after 3
d, expanded again by adding IL-2. T cell clones were generated from
these Ni-speci¢c T cell lines after the second stimulation. For cloning,
T cell blasts were seeded at 0.3 cells per well in Terasaki plates
(Nunc, Wiesbaden, Germany) in the presence of 1 mg per mL
phytohemagglutinin (PHA)-P (Murex Diagnostics Ltd, Dartford, UK),
100 U per mL IL-2, and 104 irradiated allogeneic fresh peripheral blood
mononuclear cells. Growing T cell clones were expanded and maintained
in culture by periodic stimulation in the presence of irradiated allogeneic
peripheral blood mononuclear cells, PHA and IL-2.
APC Epstein^Barr virus (EBV)-transformed B cell lines (EBV-B cells)
were prepared as described (Moulon et al, 1998) and used as APC or target
cells. The HLA-DR homozygous B cell lines WT47 (A3201, B4402,
Cw0501, DRA0102, DRB11302, DRB30301, IHW no. 9063), BSM
(B62(75), DRB10401, DR53, IHWno. 9032), HOM-2 (A0301, B27052,
Cw0102, DRA0101, DRB10101, DRB60101, IHW no. 9005), and
JESTHOM (A0201, B27052, Cw0102, DRA0101, DRB10101,
DRB60101, IHW no. 9004) originate from the International Histo-
compatibility Workshop (IHW; Marsh et al, 2001). T2 cells were obtained
from P. Cresswell (Newcomb and Cresswell, 1993), the 721.221 cell line
from P. van Endert (Shimizu and DeMars, 1989), and the receptor
de¢cient murine hybridoma 54z17 from O. Acuto (Blank et al, 1993).
Cytotoxic assays EBV-transformed B cells or other cell lines were used
as targets in a standard 4 h 51Cr-release assay (Shearer, 1974). Brie£y, targets
were labeled with Na2
51CrO4 (NEN Life Science Products, Boston,
Massachusetts) for 90 min at 371C and extensively washed. The number
of target cells was maintained constant (4103 cells per 200 mL) and
e¡ector cells were used at e¡ector/target ratios between 30:1 and 1:1 in
RPMI-FBS. NiSO4 (10
^4 M) or PHA (1 mg per mL) were added to the
round-bottom microwells at ¢xed concentrations if not otherwise
indicated and the plates centrifuged for 5 min at 40g. After 4 h at 371C
the plates were spun at 240g for 5 min, and 51Cr-release in the
supernatants was measured in triplicate in an automatic g-counter
(Topcount, Packard, Dreieich, Germany). Speci¢c lysis was calculated
according to (Shearer, 1974). All data represent the mean of triplicates with
SD less than 12%.
IL-2 secretion assay TCR transfectants (5104 cells) were cocultured
in duplicate or in triplicate in 200 mL RPMI-FBS with 5104 irradiated
(6000 rad) EBV-B cells in the presence or absence of NiSO4. After 20 h at
371C, 100 mL of the supernatant was used for a CTLL proliferation assay as
described (Grabstein et al, 1986). IL-2-dependent incorporation of 3H-
thymidine (0.4 mCi per well, 2 Ci per mmol; Amersham, Braunschweig,
Germany) was determined after 18 h in an automatic b-counter (Inotech,
Asbach, Germany).
Isolation and transfection of L1.1-derived TCR genes RNA
extraction, transcription into cDNA and analysis of TCR A and B genes by
polymerase chain reaction (PCR) screening, and DNA sequencing of PCR
products was done as described (Vollmer et al, 1997). Nomenclature for TCR
gene segments is according to (Arden et al, 1995) and CDR3 regions are
de¢ned according to Moss and Bell (1996). PCR ampli¢ed DNA of the
rearranged human TCR A- and B-chain variable genes of clone L1.1 was
inserted into pV2-15a/b expression vectors as previously described (Vollmer
et al, 1997, 1999b). These vectors contain the murine Ca or Cb sequences,
respectively, in genomic arrangement (Casorati et al, 1993).
Primers used for the leader regions (sense orientation) were
atcccagtggtccagaaaATGCTCCTGCTGCTCGTC (PrLead-VA1S3) and
acctgccttggtcccaagATGGGTCCTGGGCTTCTC (PrLead-VB24S1) with
overlaps for the respective vector promoter sequences indicated in lower
case. Anti-sense primers to the 30 ends of JA and JB, respectively, with
attached splice and BamHI (JA) or SalI (JB) restriction sites (lower case) were
gatcggatccacttacTTGGGAGAATATGAAG (JA30-splice-BamHI) or
atcgtcgactcttacCTGTGACCGTGAGCCTGGTGC (JB2S7-splice-SalI). A
BamHI restriction site in positions 214 to 219 of the AV1S3A1T sequence was
destroyed, replacing A216 by C with the overlapping PCR primers
GTATTTATCAGGCTCCACCCTGGTTG (VA1mut-sense) and CAACC-
AGGGTGGAGCCTGATAAATAC (VA1mut-anti-sense) (mutation under-
lined). PCR protocols were as described (Vollmer et al, 1999a, b). The
ampli¢cation products were fused by overlapping PCR to the untranslated
promotor regions of the pV-15a and pV-15b vectors, respectively (Vollmer
et al, 1999a), cloned into the pCR-Script vector (Stratagene, Heidelberg,
Germany) and sequenced using the Big Dye sequencing kit and a 310
Genetic Analyzer (both from Applied Biosystems, Foster City, California).
The ¢nal segments were released from pCR-Script with BamHI and SstI
(VA) or SalI and EcoRI (VB), and inserted into the correspondingly
linearized pV2-15a/b expression vectors (Vollmer et al, 1999a). TCR-a and
TCR-b vectors were linearized with ClaI or EcoRI, respectively, before
transfection by electroporation into 54z17 cells. Selection of transfected cells
was with mycophenolic acid for TCRA and G418 for TCRB (Casorati et al,
1993).
Flow cytometry and antibodies Mouse anti-human monoclonal
antibodies used for £ow cytometry were the following: CD4 (13B8.2,
Immunotech), CD8 (B9.11, Immunotech), TCR Pana/b (BMA031,
Immunotech). £uorescein isothiocyanate-conjugated goat anti-mouse
IgGþM (Hþ L) was purchased from Jackson Immuno Research
Laboratories West Drove, PA. T cells were stained at 41C in 96 well plates
(2105 cells per well) with monoclonal antibodies and £uorescein
isothiocyanate-conjugated secondary antibodies. Fluorescence was
measured in a FACScan instrument (Becton Dickinson, Mountain View,
CA). Additional antibodies, employed in lysis assays, were speci¢c for
HLA class I (W6/32, American Type Culture Collection), HLA-DR (L243,
American Type Culture Collection), HLA-DP (B7.21, American Type
Culture Collection), HLA-DQ (SVPL3, American Type Culture
Collection), CD1a (BL6, Beckman Coulter, Brea, CA), CD3 (UCHT1,
PharMingen), Fas-ligand (NOK-1, PharMingen, San Diego, CA), and
tumor necrosis factor a (Ancell, Bayport, Minnesota).
RESULTS
Non HLA-restricted cytolytic T lymphocyte (CTL) clones
from two Ni allergic donors As mentioned in the
introduction, we recently isolated a CTL clone from donor
CMO, termed NiCoA3, which revealed surprising functional
similarities to the previously described CTL clone L1.1 (from
donor IF) (Moulon et al, 1998). Both clones represent abTCRþ ,
CD8þ, CD4^ human T cells (data not shown) and were cloned
by limiting dilution from NiSO4-stimulated peripheral
mononuclear blood cells of two independent Ni-allergic
individuals. Both reacted to Ni ions presented by autologous B
cell lines by proliferation as well as by speci¢c cytolysis. In
contrast to other CD8þ T cells, however, these two clones did
not exhibit typical HLA restriction. Both responded in
proliferation and Cr-release assays to NiSO4 not only when
presented on autologous APC, but also on EBV-transformed B
cell lines from a variety of HLA unrelated donors. This has been
demonstrated previously for clone L1.1 (Moulon et al, 1998). For
clone NiCoA3 Ni-speci¢c proliferation on a panel of EBV-
transformed B cells from four di¡erent donors is shown in
Table I. Other CTL clones from various donors showed Ni-
responsiveness exclusively in combination with autologous or
HLA class I matched B cell lines (Moulon et al, 1998; and
unpublished data).
A comparison of clones L1.1 (donor IF) and NiCoA3 (donor
CMO) with a typical HLA-restricted CD8þ clone (b2 from
donor IF) in 51Cr-release assays with di¡erent target cells is
shown in Fig 1. These data reveal that clone b2 only induces
Ni-speci¢c lysis of autologous IF-B cells. In contrast, NiSO4
triggers lysis by clones L1.1 and NiCoA3 of T2 cells (lacking
HLA class II), 721.221 cells (lacking HLA class I), or Daudi cells,
which are devoid of b2-microglobulin (Seong et al, 1988), and
hence lack most class I-like molecules, including CD1. In
contrast, murine cell lines such as RMA (T lymphoma, H-2b)
or P815 (mastocytoma, H-2d) did not serve as targets, even
when transfected with the human class I molecules HLA-A2 or
HLA-B7 (data not shown).
Kill inhibition by CMA and SrCl2 From previous studies we
knew that Ni stimulation of L1.1 induced the secretion not only
of interferon-g, but also of IL-4 (Moulon et al, 1998), classifying
it as a Tc0 type of CTL. In order to elucidate the killing
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mechanisms employed by clones L1.1 and NiCoA3, we performed
51Cr-release assays in the presence of CMA. As shown in Fig
2(A,C), lysis of 721.22 target cells by both clones was strongly
inhibited by CMA, a reagent described as an inhibitor of
perforin-mediated lysis, but not of Fas-mediated lysis (Kataoka
et al, 1994, 2000). Pretreatment of CTL with SrCl2 has also been
used to inhibit perforin mediated lysis, in this case via exhaustive
degranulation (Stenger et al, 1997; Ohminami et al, 1999). In our
hands, SrCl2 reduced target cell lysis only partially by about
40% (Fig 2B), leaving open the question whether this was due
to incomplete degranulation; however, As CMA induces
selective degradation of perforin and inhibits neither Fas/Fas
ligand interaction nor cytolysis mediated by soluble factors such
as tumor necrosis factor a (Kataoka et al, 2000), perforin still
appears as the most likely candidate to explain the cytolytic
potential of our clones.
Lysis is independent of HLA and CD8, but TCR-
mediated The atypical ability of both T cell clones to lyze
targets lacking either class I or class II major histocompatibility
complex molecules might be explained by assuming that the
HLA restriction of the two clones is so promiscuous that they
recognize Ni in the context of either class I or class II major
histocompatibility complex in an allele-independent manner.
No inhibition of Ni-speci¢c lysis by monoclonal antibodies
speci¢c for HLA class I was observed, however, even when the
class II de¢cient cell line T2 was used as a target (Fig 3A). The
independence of the lytic reaction of HLA class I or class I-like
presenter molecules was most convincingly demonstrated by
the Ni-speci¢c cytolysis of the b2-microglobulin-negative Daudi
cells (Fig 1). Interestingly, L1.1-induced lysis also was not a¡ected
by antibodies to CD8 or CD4, indicating complete independence
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Figure1. Ni-speci¢c cytolysis of di¡erent target cells by CTL
clones L1.1, NiCoA3, and b2. Cr release was determined in a 4 h lysis
assay as described in Materials and Methods in the presence (¢lled symbols)
or absence (open symbols) of 1.510^4 M NiSO4.Target cells are indicated
on top. EBV-transformed B cells of donor IF are autologous to clones L1.1
and b2. The human cell line T2 (Newcomb and Cresswell, 1993) expresses
low levels of HLA-A2 (TAP de¢ciency) and lacks HLA class II. Cell line
721.221 (Shimizu and DeMars, 1989) shows no expression of HLA class I,
whereas Daudi cells do not express b2 microglobulin (Seong et al, 1988)
and, hence, are devoid of all b2 microglobulin-containing classical or non-
classical class I-like HLA surface molecules.
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Figure 2. Inhibition of lysis by CMA and SrCl2. Data show Ni-speci-
¢c lysis of 51Cr-labeled 721.221 target cells by clones L1.1 (A,B) and Ni-
CoA3 (C) at e¡ector/target ratios of 10:1 and 3:1, respectively. Final
concentrations of additions were 10^4 M NiSO4 and 200 nM CMA. SrCl2
was used at 25 mM to preincubate the T cells for 18 h according to pub-
lished procedures (Stenger et al, 1997; Ohminami et al, 1999). Cells were
then washed, counted, and subjected to Cr-release assays as above. Data re-
present means of triplicates with standard deviations indicated. Sponta-
neous Cr release (0% lysis) and maximal release induced by 1% Triton X-
100 (100% lysis) were 1,800/11,500 cpm for (A) and (C) and 780/10,700 cpm
for (B), respectively.
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Figure 3. No inhibition of L1.1-mediated cytolysis of T2 cells by
antibodies to HLA or coreceptors. Ni-speci¢c Cr release was
assayed as for Figs 1 and 2. (A) Lysis in the presence or absence of
antibodies to HLA class I, or HLA-DP, -DQ, or -DR. All antibodies
were added as 1:10 diluted culture supernatants. (B) Parallel experi-
ment with antibodies to CD1a, CD3, CD8, or CD4, all at 10 mg
per mL. Controls consisted in both experiments of 10 mg per mL of mouse
IgG1.
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of coreceptor activity (Fig 3B). In contrast, an antibody against
CD3 reduced the lytic reaction (Fig 3B), pointing to the
abTCR as a critical structure in Ni recognition by L1.1.
Furthermore, antibodies to human abTCR or human CD3
could sensitize Fc receptor-bearing murine P815 cells for lysis by
clone L1.1 as e¡ectively as PHA (Fig 4). This experiment also
shows that clone L1.1, even though it lacks Ni-speci¢c reactivity
against the murine P815 line, is perfectly capable of lysing these
cells when the contact is established either via PHA or via
antibodies directed against the TCR complex.
Gene transfection assigns Ni speci¢city to abTCR Although
all data pointed to the TCR of clone L1.1 as mediating
cytotoxicity, they did not formally prove that also the speci¢city
for Ni was de¢ned by that same TCR. Moreover, they did not
exclude other structures than the TCR, e.g., natural killer
receptors, from de¢ning Ni speci¢city.
To obtain more insight into the structures involved in Ni-
induced T cell activation we analyzed the primary TCR
structures of clones L1.1 and NiCoA3. First, we identi¢ed their
VA/VB usage by reverse transcription^PCR screening with
VA/CA andVB/CB primer pairs as previously described (Vollmer
et al, 1997). Subsequent DNA sequencing of the ampli¢cation
products identi¢ed the rearranged J-elements as well as the V^J
joining sequences. These sequences revealed one productively
rearranged a- and b-chain for each of the two clones. As shown
inTable II, neither a nor b sequences of the twoTCR share any
homologies in their amino acid sequences nor do they express the
invariant AV24 sequence of typical natural killer T cells (Couedel
et al, 1998). L1.1 employs AV1/JA30 and BV24/JB2S7, whereas
clone NiCoA3 uses AV16/JA18 and BV6/JB2S3. In addition, both
TCR di¡er in the lengths of the CDR3 regions of their a chains
as well as of their b chains.
Final evidence that the TCR, at least of clone L1.1, represents
the only structure de¢ning the ‘‘unrestricted’’ Ni reactivity came
from TCR transfection experiments. The rearranged TCR-a
genes and TCR-b genes of L1.1 were isolated by PCR using a
leader-speci¢c sense primer and an anti-sense primer
complementary to the 30 end of the J-region (see Materials and
Methods). Following previously published procedures (Vollmer et
al, 1999a), the human variable sequences were cloned into
expression vectors containing the murine Ca or Cb gene
segments, respectively, in genomic arrangement. Transfection of
these genes by electroporation into the TCR-ab-de¢cient
murine T cell hybridoma 54z17 resulted in surface expression of
the receptor in hybridomaYo7 (Fig 5A).
Functionally, this expression enabled hybridoma Yo7 to
respond to APC and NiSO4 by secretion of IL-2 (Fig 5B). The
data in Fig 5(B) also reveal that, like clone L1.1, the transfectant
Figure 5. Functional expression of L1.1 TCR in murine
hybridomaYo7. Expression vectors containing the rearranged
genes for the L1.1 TCR a- and b-chains were prepared and
transfected into murine 54z17 cells as described in Materials and
Methods. Screening of transfectants for TCR expression and Ni
reactivity resulted in the isolation of hybridomaYo7. (A) FACS
staining with anti-murine CD3e (145^2C11 (Leo et al, 1987) and
£uorescein isothiocyanate-conjugated goat anti-hamster immu-
noglobulin (¢lled histogram). Open histogram shows control
staining with second antibody only. (B) IL-2 production by hy-
bridomaYo7 upon stimulation with 1.510^4 M NiSO4 in the
absence (none) or presence of indicated APC. WT47, BSM,
HOM-2, and JESTHOM are allogeneic (see Materials and
Methods for HLA typing), whereas EBV-IF represents an autolo-
gous B cell line. P815/A2 represents a mouse mastocytoma line
transfected with human HLA-A2 and b2-microglobulin, L-
DR1, a HLA-DR1-transfected murine ¢broblast line. T2 cells
lack HLA class II, 721.221 cells lack HLA class I. IL-2 was deter-
mined by CTLL assay as described in Materials and Methods.
Upper and lower panel are from two independent experiments.
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Figure 4. Antibody-mediated lysis of murine P815 cells by clone
L1.1. For controls, Cr-labeled P815 target cells were incubated with L1.1
cells at an e¡ector/target ratio of 3:1 without additions (Ctr.), with
1.510^4 M NiSO4 (Ni), or with 5 mg PHA per mL. In the tests, the
Fc-receptor bearing 51Cr-P815 cells were preincubated for 30 min with
antibodies (10 mg per mL) to CD8, CD3, orTCR, or with mouse IgG con-
trol and then added to L1.1 cells in the absence of Ni (e¡ector/target¼ 3:1).
Table I. NiSO4 drives proliferation of clone NiCoA3 ON
allogeneic EBV-B cells
APCa no Antigenb NiSO4
c
None 176723 196741
JESTHOM 1.0447144 28.0957369
HOM-2 197767 14.1277576
BSM 421759 30.3897828
WT47 575718 28.32071035
aFor HLA expression on the di¡erent B cell lines see Materials and Methods.
bNiCoA3 T cells (2104) with or without 2104 irradiated B cells (6000 rad)
were incubated in 200 mL RPMI-FBS at 371C. After 48 h 0.4 mCi per well 3H-
thymidine was added for 18 h, cells lyzed, and DNA collected on GF/A ¢lters.
Radioactivity was determined in a beta-counter (Inotech, Asbach, Germany).
Data represent cpm7maximal deviation between duplicates.
cAs in (b), but in the presence of 10^4 M NiSO4.
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Yo7 responded to Ni on APC of di¡erent origin, including those
lacking either class I (721.221) or class II major histocompatibility
complex (T2). These data identify the TCR-ab as the only
essential structure mediating the ‘‘unrestricted’’ Ni speci¢city of
clone L1.1. The transfectant, even though equipped with murine
adhesion molecules, did also not respond to Ni on murine P815
or L cells. Figure 5(B) shows data for P815 transfected with HLA-
A2 plus b2-microglobulin and L cells transfected with HLA-DR1.
DISCUSSION
Ni contact dermatitis, due to its high frequency particularly in
the female population, is often regarded as a general example for
allergic contact hypersensitivity. There is no doubt that Ni al-
lergy, like other hapten induced contact hypersensitivity reac-
tions, is mediated by allergen-speci¢c T cells (Sinigaglia, 1994;
Weltzien et al, 1996; Griem et al, 1998). In contrast to several other
contact allergens, however, the molecular basis for the activation
of T lymphocytes by Ni ions remains obscure.This is particularly
true for CD8þ cytotoxic T cells, which have been identi¢ed as
the major T cell subpopulation responsible for the pathology of
contact hypersensitivity in mouse models (Bour et al, 1995; Mar-
tin et al, 2000). In human Ni allergy CD8þ Tcells have also been
suspected as essential causative agents (Cavani et al, 1997, 2001);
however, unlike in the murine system, the isolation, cloning,
and long-term cultivation of human cytotoxic T cells in general,
and of Ni-speci¢c CD8þ T cells in particular, have proven ex-
ceedingly di⁄cult.
In this study we present the ¢rst detailed structure^function
analysis of a TCR derived from a Ni-reactive, CD8þ, cytotoxic
T cell clone. This clone L1.1 was originally considered as a rare
exception (Moulon et al, 1998) because, unlike the majority of
CD8þ T cells from Ni-sensitized patients, it did not appear to
be restricted by known HLA or HLA-like molecules; however,
in an independent cloning from a di¡erent donor we again iso-
lated a Ni-reactive cytotoxic clone (NiCoA3) with highly similar
properties (Table I, Fig 1). This indicates that the occurrence of
non-HLA-restricted CTL in the peripheral blood of Ni-sensitized
individuals is frequent enough to imply a functional role of such
T cells in Ni allergy.
Our experimental data demonstrate that the two CTL clones
express absolutely ‘‘typical’’ TCR-ab di¡ering from each other
inV and J usage as well as in the length and sequences of their a
chain and b chain CDR3 loops (Table II). The mode of target
cell lysis appears not to involve the Fas/Fas ligand pathway be-
cause it is strongly counteracted by CMA (Fig 2), which leads
to degradation of perforin (Kataoka et al, 1994, 2000). The only
partial inhibition by SrCl2 (Fig 2B), on the other hand, might
indicate that perforin and granzymes are not necessarily the only
mediators of target cell death. Ni reactivity, however, is clearly
controlled by the TCR-ab (Figs 3 and 4), and it is neither re-
stricted by HLA class I nor by HLA class II (Figs 1 and 3). Func-
tional studies of the L1.1 receptor expressed in a murine
hybridoma revealed that the TCR heterodimer is necessary and
su⁄cient to de¢ne HLA-independent Ni speci¢city (Fig 5).
Several murine cell lines (RMA, P815), even when transfected
with human class I genes, were not lyzed in by L1.1 in the
presence of Ni (not shown). Furthermore, the murine hybridoma
expressing the L1.1 TCR could not be activated by murine cells,
expressing human class I or class II antigens (Fig 5B). This points
to an involvement of unidenti¢ed, but selectively expressed hu-
man surface structures, which are neither HLA class II nor any
b2-microglobulin-containing class I or class I-like molecule, in-
cluding CD1. Previous experiments demonstrating a lack of Ni
stimulation of clone L1.1 by glutaraldehyde-¢xed APC (Moulon
et al, 1998) indicated a requirement for metabolically active APC,
whereas in contrast, blocking of golgi transport by Brefeldin A
did not inhibit stimulation (Moulon, unpublished data). Finally,
APC which were pulsed with Ni salts and washed prior to stimu-
lation failed to activate clone L1.1 (Moulon et al, 1998), indicating
a necessity for the permanent presence of Ni ions in the medium.
The structural nature of the epitopes recognized by the TCR
of clones L1.1 or NiCoA3 has not yet been identi¢ed; however,
the lack of HLA involvement as well as the failure of Brefeldin
A to inhibit activation speak against a role of so-called cryptic
peptides (Griem et al, 1996). Further, it appears unlikely that Ni
ions form stable epitopes on APC able to be recognized by the
L1.1 TCR, because APC lose their stimulatory capacity upon re-
moval of the surplus of unabsorbed Ni (Moulon et al, 1998).We
therefore favor a model in which Ni ions stabilize loose contacts
between TCR and as yet unidenti¢ed (possibly Ni-induced) sur-
face protein(s) on the APC.
The fact that CTL of such untypical reactivity have been found
in two cloning procedures from Ni-stimulated peripheral T cells
of two independent donors points to a rather frequent occurrence
of such cells in Ni-allergic patients. As previously described
(Moulon et al, 1998), clone L1.1 expresses the CLA antigen and,
hence, is likely to migrate to the skin, where it might well be
activated by a variety of di¡erent cells as soon as Ni ions become
available. The lack of requirement for very speci¢c APC may en-
dow such cells with an exceptional amplifying potential, assign-
ing to them an important role in the pathology of Ni contact
dermatitis; however, whether this role is to be found in the pro-
motion or the suppression of allergic symptoms remains to be
elucidated. As previously shown, the activated clone L1.1 not only
secretes interferon-g, but also signi¢cant amounts of IL-4 (Mou-
lon et al, 1998), classifying it as a Tc0 rather than a Tc1 type of
CTL. Interestingly, this applies to six of 11 previously analyzed
CD8þ, Ni-reactive T cell clones (Moulon et al, 1998).
In conclusion, this ¢rst structure/function analysis of a Ni-re-
active human TCR from a CD8þ cytotoxic T cell clone reveals
that Ni coordination complexes may activate speci¢c T cells in
many di¡erent ways. The ¢nding that on the side of the human
APC even non-HLA structures may participate in such TCR-ac-
tivating complexes adds a new facet to the phenomenon of Ni
allergy. This property, which has not been observed for other
haptens, may be one of the reasons of the exceptionally e¡ective
sensitizing potential of Ni in humans.
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Table II. Sequences of CDR1, 2 and 3 in TCR-a chains and TCR-b chains of clones L1.1 and NiCoA3a
Clone Donor V-element CDR1 CDR2 CDR3 J-element
L1.1b IF AV1S3A1T SSSVSVY KYLSGSTLV CA VSDQNRDDKII FG AJ30
NiCoA3 CMO AV16S1A1T SVSGNPY KYITGDNLV CA VRDIKRGSTLGRLY FG AJ18
L1.1b IF BV24S1A2T TLNHNV HYYDKDFNNEADT CAT SREGWGRVDEQY FG BJ2S7
NiCoA3 CMO BV6S6A2T ISSHAT YFQNEAQLDKSGL CAS SRTLGQGSFTDTQY FG BJ2S3
aAmino acid sequences are shown in single letter code. CDR are de¢ned according to (Arden et al, 1995) for CDR1 and CDR2 and to (Moss and Bell, 1996) for CDR3.
V and J sequences are base-identical to the indicated elements as published byArden et al (1995).
bData fromVollmer et al (1997).
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